UTHR - United Therapeutics Corp

Insider Sale by Olian Judy D. (Dir)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

2 days ago, Olian Judy D., serving as Dir at United Therapeutics Corp (UTHR), sold 200 shares at $535.44 per share, for a total transaction value of $107,088.00. Following this transaction, Olian Judy D. now holds 4,445 shares of UTHR.

This sale represents a 4.00% decrease in Olian Judy D.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, March 16, 2026 and publicly disclosed via SEC Form 4 filing on Monday, March 16, 2026, meaning the disclosure happened on the same day as the trade.

United Therapeutics Corp operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Olian Judy D.

Dir

Dr. Judy D. Olian is a Director at Ares Management Corporation (ARES), a position she has held since April 30, 2014.[[1]](https://www.ares.com/about-ares-management-corporation/our-team/dr-judy-d-olian)[[2]](https://www.marketscreener.com/insider/JUDY-OLIAN-A02BJN/) As a corporate insider, she has recently engaged in trading activities at the firm.[user query context] Born and raised in Australia, Dr. Olian is President Emeritus of Quinnipiac University, having served as President from 2018 to 2025.[[1]](https://www.ares.com/about-ares-management-corporation/our-team/dr-judy-d-olian)[[3]](https://unither.com/about-us/leadership/judy-olian)[[5]](https://www.qu.edu/faculty-and-staff/judy-olian/) Dr. Olian has a distinguished career in higher education leadership, including as Dean of the UCLA Anderson School of Management and John E. Anderson Chair in Management (2006-2018), Dean and Professor of Management at Pennsylvania State University's Smeal College of Business (2001-2006), and various roles at the University of Maryland's Robert H. Smith School of Business.[[1]](https://www.ares.com/about-ares-management-corporation/our-team/dr-judy-d-olian)[[3]](https://unither.com/about-us/leadership/judy-olian)[[4]](https://en.wikipedia.org/wiki/Judy_D._Olian) Her expertise focuses on organizational design, human resource systems, incentives, and top management teams.[[1]](https://www.ares.com/about-ares-management-corporation/our-team/dr-judy-d-olian)[[3]](https://unither.com/about-us/leadership/judy-olian) She serves on boards including United Therapeutics Corporation (since 2015), Mattel, Inc., Hartford HealthCare, and others, and was Chair of AACSB International.[[2]](https://www.marketscreener.com/insider/JUDY-OLIAN-A02BJN/)[[3]](https://unither.com/about-us/leadership/judy-olian)[[5]](https://www.qu.edu/faculty-and-staff/judy-olian/)[[6]](https://www.knightcommission.org/judy-olian/) Dr. Olian holds a B.S. in Psychology from Hebrew University, Jerusalem, and M.S. and Ph.D. in Industrial Relations from University of Wisconsin-Madison.[[1]](https://www.ares.com/about-ares-management-corporation/our-team/dr-judy-d-olian)[[3]](https://unither.com/about-us/leadership/judy-olian)[[5]](https://www.qu.edu/faculty-and-staff/judy-olian/)

View full insider profile →

Trade Price

$535.44

Quantity

200

Total Value

$107,088.00

Shares Owned

4,445

Trade Date

Monday, March 16, 2026

2 days ago

SEC Filing Date

Monday, March 16, 2026

HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC

About United Therapeutics Corp

Company Overview

No company information available
View news mentioning UTHR

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4839253

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime